CS logo
small CS logo
Institute of Clinical Oncology

Tbilisi, Georgia
Hospital in Tbilisi
QQGF+7V9, ლუბლიანას ქუჩა, Tbilisi

About Institute of Clinical Oncology


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Helsinn Healthcare SA
2
Hoffmann-La Roche
2
Queen Mary University of London
2
Biocad
1
Bioven Europe
1
EMD Serono Research & Development Institute, Inc.
1
EirGenix, Inc.
1
Incyte Corporation
1
PharmaMar
1
Prestige Biopharma Limited
1
Shanghai Henlius Biotech
1
Total Rows: 14

Clinical Trials at Institute of Clinical Oncology


During the past decade, Institute of Clinical Oncology conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 5 clinical trials were completed, i.e. on average, 35.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years22111133332211110000001100222200Started TrialsCompleted Trails2015201620172018201920202021202201234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer
2014-01-31
2021-06-04
Completed
1,846
Safety & Efficacy Study of EGF Cancer Vaccine to Treat Stage IV Biomarker Positive, Wild Type EGF-R NSCLC Patients
2015-05-01
2019-09-06
Terminated
106
A Randomized Study of AZD2014 in Combination With Fulvestrant in Metastatic or Advanced Breast Cancer
2014-01-01
2020-07-31
Unknown status
333
PAKT: AZD5363 in Combination With Paclitaxel in Triple-Negative Advanced or Metastatic Breast Cancer
2014-05-01
2020-06-01
Unknown status
140
An Efficacy and Safety Study of Intravenous Palonosetron Administered as an Infusion and as a Bolus for the Prevention of Nausea and Vomiting
2015-10-01
2016-03-01
Completed
441
Randomized Phase 2 Study of Atezolizumab and Entinostat in Patients With aTN Breast Cancer With Phase 1b Lead In
2016-05-01
2021-03-10
Completed
81
Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer
2017-06-01
2020-03-26
Completed
483
A Study Comparing MB02 and Avastin® in Subjects With Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
2018-02-06
2020-02-27
Completed
627

Rows per page:

1–17 of 17

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Institute of Clinical Oncology" #1 sponsor was "Helsinn Healthcare SA" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Queen Mary University of London" with 2 trials sponsored, "Biocad" with 1 trials sponsored and "Bioven Europe" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Institute of Clinical Oncology" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Cancer Research UK" with 1 trials as a collaborator, "GORTEC (Head and Neck Oncology and Radiotherapy Group)" with 1 trials as a collaborator, "George Clinical Pty Ltd" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHelsinn Healthcare SA: 2Helsinn Healthcare SA: 2Hoffmann-La Roche: 2Hoffmann-La Roche: 2Queen Mary Universityof London: 2Queen Mary Universityof London: 2Biocad: 1Biocad: 1Bioven Europe: 1Bioven Europe: 1EMD Serono Research &Development Institute,Inc.: 1EMD Serono Research &Development Institute,Inc.: 1EirGenix, Inc.: 1EirGenix, Inc.: 1Incyte Corporation: 1Incyte Corporation: 1PharmaMar: 1PharmaMar: 1Prestige Biopharma Limited: 1Prestige Biopharma Limited: 1

Created with Highcharts 11.1.0Top CollaboratorsAstraZeneca: 2AstraZeneca: 2Cancer Research UK: 1Cancer Research UK: 1GORTEC (Head andNeck Oncology andRadiotherapy Group): 1GORTEC (Head andNeck Oncology andRadiotherapy Group): 1George Clinical Pty Ltd: 1George Clinical Pty Ltd: 1Merck KGaA,Darmstadt, Germany: 1Merck KGaA,Darmstadt, Germany: 1PSI CRO: 1PSI CRO: 1Roche Pharma AG: 1Roche Pharma AG: 1The Physicians'Services IncorporatedFoundation: 1The Physicians'Services IncorporatedFoundation: 1Zai Lab (Shanghai) Co., Ltd.: 1Zai Lab (Shanghai) Co., Ltd.: 1

Clinical Trials Conditions at Institute of Clinical Oncology


According to Clinical.Site data, the most researched conditions in "Institute of Clinical Oncology" are "Breast Cancer" (3 trials), "Non-small Cell Lung Cancer" (2 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Cervical Cancer" (1 trials) and "Chemotherapy-Induced Nausea and Vomiting" (1 trials). Many other conditions were trialed in "Institute of Clinical Oncology" in a lesser frequency.

Clinical Trials Intervention Types at Institute of Clinical Oncology


Most popular intervention types in "Institute of Clinical Oncology" are "Drug" (16 trials), "Biological" (3 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Paclitaxel" (6 trials), "Placebo" (6 trials), "Carboplatin" (3 trials), "Bevacizumab" (2 trials) and "Cisplatin" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Institute of Clinical Oncology


The vast majority of trials in "Institute of Clinical Oncology" are 11 trials for "All" genders and 6 trials for "Female" genders.

Clinical Trials Status at Institute of Clinical Oncology


Currently, there are NaN active trials in "Institute of Clinical Oncology". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Institute of Clinical Oncology, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Institute of Clinical Oncology, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 14Phase 3: 14Phase 2: 4Phase 2: 4Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 7Completed: 7Recruiting: 5Recruiting: 5Active, not recruiting: 2Active, not recruiting: 2Unknown status: 2Unknown status: 2Terminated: 1Terminated: 1

Departments of Institute of Clinical Oncology


Institute of Clinical Oncology has several departments that took part in Clinical trials: "Scientific Research National Center of Dermatology and Venereology LLC" - 2 trials, "Hepatology Clinic Hepa" - 2 trials